A. Mohamed Sikkander et al. trans. 2025. A 2025 meta-analysis in non–small-cell lung cancer (NSCLC) indicates glucocorticoid administration is significantly associated with worse progression-free survival (PFS) and overall survival (OS) for patients on ICIs. World Journal of Applied Medical Sciences. 2, 11 (Nov. 2025), 1–3. DOI:https://doi.org/10.65336/WJAMS.2025.21101.